Revvity, Inc. (RVTY) Misses Q3 EPS by 1c, updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Revvity (RVTY) sinks after third quarter results disappoint investors
October 30, 2023 11:11 AM EDTShares of health sciences company Revvity (NYSE: RVTY) plunged after it reported disappointing results for the third quarter of 2023 and updated its guidance. Management said the shortfall was due to an increasingly challenging end market environment.
Revvity reported third quarter adjusted EPS of $1.18 on revenue of $671 million. Consensus was expecting EPS of $1.19 and revenue of $695 million. The company said it expects... More
